AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
A longitudinal quantitative MRI study of community-based patients with chronic epilepsy and newly diagnosed seizures: Methodology and preliminary findings
Authors: Liu, RSN Lemieux, L Bell, GS Bartlett, PA Sander, JWAS Sisodiya, SM Shorvon, SD Duncan, JS
Citation: Rsn. Liu et al., A longitudinal quantitative MRI study of community-based patients with chronic epilepsy and newly diagnosed seizures: Methodology and preliminary findings, NEUROIMAGE, 14(1), 2001, pp. 231-243
Comparing the cost of epilepsy across eight European countries
Authors: Heaney, DC Sander, JWAS Shorvon, SD
Citation: Dc. Heaney et al., Comparing the cost of epilepsy across eight European countries, EPILEPSY R, 43(2), 2001, pp. 89-95
Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort
Authors: Lhatoo, SD Johnson, AL Goodridge, DM MacDonald, BK Sander, JWAS Shorvon, SD
Citation: Sd. Lhatoo et al., Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort, ANN NEUROL, 49(3), 2001, pp. 336-344
The treatment of epilepsy in developing countries: where do we go from here?
Authors: Scott, RA Lhatoo, SD Sander, JWAS
Citation: Ra. Scott et al., The treatment of epilepsy in developing countries: where do we go from here?, B WHO, 79(4), 2001, pp. 344-351
Long-term continuation of levetiracetam in patients with refractory epilepsy
Authors: Krakow, K Walker, M Otoul, C Sander, JWAS
Citation: K. Krakow et al., Long-term continuation of levetiracetam in patients with refractory epilepsy, NEUROLOGY, 56(12), 2001, pp. 1772-1774
The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed upprospectively over 11-14 years
Authors: Lhatoo, SD Sander, JWAS Shorvon, SD
Citation: Sd. Lhatoo et al., The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed upprospectively over 11-14 years, J NE NE PSY, 71(5), 2001, pp. 632-637
The clinical impact of epilepsy genetics (vol 70, pg 428, 2001)
Authors: Johnson, MR Sander, JWAS
Citation: Mr. Johnson et Jwas. Sander, The clinical impact of epilepsy genetics (vol 70, pg 428, 2001), J NE NE PSY, 71(4), 2001, pp. 567-567
The clinical impact of epilepsy genetics
Authors: Johnson, MR Johnson, MR Sander, JWAS Sander, JWAS
Citation: Mr. Johnson et al., The clinical impact of epilepsy genetics, J NE NE PSY, 70(4), 2001, pp. 428-430
Temporal lobe epilepsy following febrile seizures: Unusually prolonged latent periods
Authors: Lhatoo, SD Sander, JWAS Fish, D
Citation: Sd. Lhatoo et al., Temporal lobe epilepsy following febrile seizures: Unusually prolonged latent periods, EUR NEUROL, 46(3), 2001, pp. 165-166
Adverse event monitoring in lamotrigine patients: A pharmacoepidemiologic study in the United Kingdom
Authors: Wong, ICK Mawer, GE Sander, JWAS
Citation: Ick. Wong et al., Adverse event monitoring in lamotrigine patients: A pharmacoepidemiologic study in the United Kingdom, EPILEPSIA, 42(2), 2001, pp. 237-244
Long-term treatment retention with topiramate - Reply
Authors: Lhatoo, SD Sander, JWAS Wong, ICK
Citation: Sd. Lhatoo et al., Long-term treatment retention with topiramate - Reply, EPILEPSIA, 42(2), 2001, pp. 290-291
A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy
Authors: Wong, ICK Mawer, GE Sander, JWAS Lhatoo, SD
Citation: Ick. Wong et al., A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy, EPILEPSIA, 42(10), 2001, pp. 1354-1358
The treatment gap in epilepsy: The current situation and ways forward
Authors: Meinardi, H Scott, RA Reis, R Sander, JWAS
Citation: H. Meinardi et al., The treatment gap in epilepsy: The current situation and ways forward, EPILEPSIA, 42(1), 2001, pp. 136-149
The epidemiology of epilepsy and learning disability
Authors: Lhatoo, SD Sander, JWAS
Citation: Sd. Lhatoo et Jwas. Sander, The epidemiology of epilepsy and learning disability, EPILEPSIA, 42, 2001, pp. 6-9
Stopping drug therapy in epilepsy
Authors: Lhatoo, SD Sander, JWAS
Citation: Sd. Lhatoo et Jwas. Sander, Stopping drug therapy in epilepsy, CUR PHARM D, 6(8), 2000, pp. 861-863
Sudden unexpected death in patients with epilepsy - Definition, epidemiology and therapeutic implications
Authors: Langan, Y Sander, JWAS
Citation: Y. Langan et Jwas. Sander, Sudden unexpected death in patients with epilepsy - Definition, epidemiology and therapeutic implications, CNS DRUGS, 13(5), 2000, pp. 337-349
Factors predicting prognosis of epilepsy after presentation with seizures
Authors: MacDonald, BK Johnson, AL Goodridge, DM Cockerell, OC Sander, JWAS Shorvon, SD
Citation: Bk. Macdonald et al., Factors predicting prognosis of epilepsy after presentation with seizures, ANN NEUROL, 48(6), 2000, pp. 833-841
Carbamazepine in comparative trials: Pharmacokinetic characteristics too often forgotten - Reply from the authors
Authors: Arroyo, S Sander, JWAS
Citation: S. Arroyo et Jwas. Sander, Carbamazepine in comparative trials: Pharmacokinetic characteristics too often forgotten - Reply from the authors, NEUROLOGY, 55(1), 2000, pp. 155-155
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
Authors: Lhatoo, SD Sander, JWAS Wong, ICK
Citation: Sd. Lhatoo et al., Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults, NEUROLOGY, 54(1), 2000, pp. 270-271
Effects of topiramate on cognitive function
Authors: Thompson, PJ Baxendale, SA Duncan, JS Sander, JWAS
Citation: Pj. Thompson et al., Effects of topiramate on cognitive function, J NE NE PSY, 69(5), 2000, pp. 636-641
Neurocysticercosis and epilepsy in developing countries
Authors: Pal, DK Carpio, A Sander, JWAS
Citation: Dk. Pal et al., Neurocysticercosis and epilepsy in developing countries, J NE NE PSY, 68(2), 2000, pp. 137-143
Sudden unexpected death in epilepsy: a series of witnessed deaths
Authors: Langan, Y Nashef, L Sander, JWAS
Citation: Y. Langan et al., Sudden unexpected death in epilepsy: a series of witnessed deaths, J NE NE PSY, 68(2), 2000, pp. 211-213
Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countries
Authors: Heaney, DC Shorvon, SD Sander, JWAS Boon, P Komarek, V Marusic, P Dravet, C Perucca, E Majkowski, J Lima, JL Arroyo, S Tomson, T Ried, S van Donselaar, C Eskazan, E Peeters, P Carita, P Tjong-a-Hung, I Myon, E Taieb, C
Citation: Dc. Heaney et al., Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countries, EPILEPSIA, 41, 2000, pp. S37-S44
Prognostic factors affecting long-term retention of topiramate in patientswith chronic epilepsy
Authors: Lhatoo, SD Wong, ICK Sander, JWAS
Citation: Sd. Lhatoo et al., Prognostic factors affecting long-term retention of topiramate in patientswith chronic epilepsy, EPILEPSIA, 41(3), 2000, pp. 338-341
Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy
Authors: Lhatoo, SD Wong, ICK Polizzi, G Sander, JWAS
Citation: Sd. Lhatoo et al., Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy, EPILEPSIA, 41(12), 2000, pp. 1592-1596
Risultati: 1-25 | 26-42